Showing 461 - 480 results of 599 for search '"University College London"', query time: 0.08s Refine Results
  1. 461

    Utilities Associated with the Treatment of Growth Hormone Deficiency (GHD): A Time Trade-off (TTO) Study in the UK and Canada by Kirsch S, Butler G, Jensen LDF, Okkels A, Yssing C, Håkan-Bloch J

    Published 2025-01-01
    “…Susan Kirsch,1 Gary Butler,2 Lasse de Fries Jensen,3 Anna Okkels,4 Cecilie Yssing,4 Jonas Håkan-Bloch3 1Department of Pediatric Endocrinology, Hospital for Sick Children, Toronto and Oak Valley Health Hospital, Markham, Ontario, Canada; 2Department of Paediatric Endocrinology, University College London Hospitals, and UCL Great Ormond Street Institute of Child Health, London, UK; 3Novo Nordisk, Søborg, 2860, Denmark; 4EY Godkendt Revisionspartnerselskab, Frederiksberg, 2000, DenmarkCorrespondence: Lasse de Fries Jensen, Novo Nordisk, Vandtårnsvej 108-110, Søborg, 2860, Denmark, Tel +45 34482020, Email LDFJ@novonordisk.comPurpose: Growth hormone deficiency (GHD) causes decreased growth rate in children, resulting in short stature in childhood and adulthood. …”
    Get full text
    Article
  2. 462
  3. 463
  4. 464

    A Systematic Review Uncovering Modifiable Influences on Statin Adherence by Rosenberg J, Lampridou S, Moores A, Garfield S, Wingfield D, Judah G

    Published 2025-01-01
    “…Mary’s Hospital, London, UK; 3School of Pharmacy, University College London, London, UK; 4Hammersmith and Fulham Partnership, North End Medical Centre, London, UKCorrespondence: Javiera Rosenberg, Department of Surgery & Cancer, Imperial College London, St Mary’s Hospital, Praed Street, London, UK, W2 1NY, Email j.rosenberg22@imperial.ac.ukAbstract: Statins are effective in reducing cardiovascular disease (CVD) risk, but adherence rates remain low globally. …”
    Get full text
    Article
  5. 465
  6. 466
  7. 467
  8. 468
  9. 469
  10. 470
  11. 471
  12. 472
  13. 473
  14. 474
  15. 475
  16. 476
  17. 477
  18. 478
  19. 479
  20. 480